Mewburn Ellis LLP

Mewburn Ellis LLP is one of the UK's largest firms of European Patent Attorneys, European Trade Mark Attorneys and European Design Attorneys, with offices in London, Bristol, Manchester and Cambridge.  Our work covers a wide range of technologies and  we offer our clients unrivalled expertise and outstanding service, whether they are an independent inventor or a large multinational.

Biotech Patents Law Firm of the Year in England 2012, 2013  - Corporate INTL Magazine

Website:
www.mewburn.com
Organisation type
Keywords
patent attorney,trademarks
Dr Christopher Casley
Dr Christopher Casley
Partner and Patent Attorney 

Molecular Profiles

Molecular Profiles is a UK-based CDMO that specialises in advanced characterisation, R&D, clinical manufacturing and analytical services. Assisting pharmaceutical, biopharmaceutical and healthcare companies worldwide, its experienced scientists are renowned for resolving tough development issues and dealing with intellectual property litigation.

 Its early-stage services extend from pre-formulation, formulation development and solid-state screening. Supporting a dedicated in-house technical group that specialises in complex research science, its strategic alliances allow the firm to develop challenging molecules and accelerate compounds to clinic.

The company recently created an enabling technologies division, which brings together several early stage screening capabilities with the aim of supporting companies with the development of effective and bioavailable drug products.

 Molecular Profiles shares a partnership with XenoGesis that adds additional expertise in preclinical drug metabolism and pharmacokinetics (DMPK) to its enabling technologies platform. The alliance helps drug developers in the initial design and selection of compounds for key DMPK and ADME studies, as well as supporting lead candidates, which have solubility issues during formulation development.

 Complementing its development and consulting divisions, the company’s state-of-the-art clinical manufacturing facility handles a range of non-sterile dosage forms such as solids, liquids, semi-solids and inhaled products, including controlled drugs and potent compounds.

Organisation type
Keywords
CDMO,hot melt extrusion,contract,IMP,pharmaceuticals,development,poorly,soluble
Jon Faulkes
Business Development Manager